Annual report [Section 13 and 15(d), not S-K Item 405]

Net Loss Per Share - Schedule of Outstanding Shares of Potentially Dilutive Securities (Details)

v3.26.1
Net Loss Per Share - Schedule of Outstanding Shares of Potentially Dilutive Securities (Details) - shares
 12 Months Ended
Dec. 31, 2025
Dec. 31, 2024
Schedule of Outstanding Shares of Potentially Dilutive Securities [Line Items]    
Antidilutive Securities 18,796,272 19,498,672
Options to purchase common stock [Member]    
Schedule of Outstanding Shares of Potentially Dilutive Securities [Line Items]    
Antidilutive Securities 2,033,114 1,367,114
Warrants to purchase common stock [Member]    
Schedule of Outstanding Shares of Potentially Dilutive Securities [Line Items]    
Antidilutive Securities 478,419 478,419
Restricted Stock Units [Member]    
Schedule of Outstanding Shares of Potentially Dilutive Securities [Line Items]    
Antidilutive Securities 3,677 2,177
Common stock issuable upon conversion of Series B-2 convertible preferred stock [Member]    
Schedule of Outstanding Shares of Potentially Dilutive Securities [Line Items]    
Antidilutive Securities 300,000
Common stock issuable upon conversion of Series A-2 Prime convertible preferred stock [Member]    
Schedule of Outstanding Shares of Potentially Dilutive Securities [Line Items]    
Antidilutive Securities 462,245 1,255,145
Warrants to purchase convertible preferred stock [Member]    
Schedule of Outstanding Shares of Potentially Dilutive Securities [Line Items]    
Antidilutive Securities 15,818,817 16,095,817